EU Migraine Market Analysis

$3,500.00$7,500.00

  • Type: Common Disease Area
  • Published : February 2022
  • Region: Europe
  • Country: Other
  • Report ID : 5049

  • Format: PPT, PDF

EU Migraine Market Analysis: Segmented by Drug type, Treatment, Route of Administration, Distribution Channel, and End-users – Growth, Market Size, Future Prospects & Competitive Analysis, 2020 – 2028

Clear
SKU: 5049 Categories: ,

Report Description of the EU Migraine Drug Market

Research Scope and Assumption

  • The report provides the market value for the base year 2020 and a yearly forecast up to 2028 in terms of revenue (USD billion)
  • The key industry dynamics, regulatory scenario, reimbursement scenario, major market trends, and drug markets are evaluated to understand their impacts on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis
  • We have used the combination of top-down and bottom-up approach for market sizing, analyzing key regional markets, dynamics, and trends for various solutions, services, and end uses
  • All market estimates and forecasts have been validated through primary interviews with the Key Industry Players (KIPs) and secondary analysis
  • Inflation has not been accounted for in order to estimate and forecast the market
  • Numbers may not add up due to rounding off

Reason to buy the report:

  • Facilitate decision-making based on strong current and forecast data for EU Migraine Drug Market
  • Develop strategies based on the latest regulatory framework
  • Strategically analyze micro-markets with respect to individual growth trends, future prospects, and their contribution to the market
  • Analyze competitive developments such as expansions, investments, mergers & acquisitions, new product developments, and research & developments in the Migraine Drug market
  • Analyze the opportunities in the market for stakeholders and draw a competitive landscape for market leaders
  • To strategically profile key players and comprehensively analyze their market shares and core competencies
  • We have technically sound team which do a deep dive research and also provide strategy based consulting analysis

EU Migraine Drugs Market Executive Summary

EU Migraine Drugs Market, 2020-2028’to its database of market research collaterals consisting of overall market scenario with prevalent and future growth prospects, among other growth strategies used by key players to stay ahead of the game. Additionally, recent trends, mergers and acquisitions, growth analysis along with challenges that are affecting the growth of the market are also stated in the report.

Market Size and Key Findings

The EU Migraine Market size stood at around USD 1.22 billion in 2021 and is projected to reach USD xx billion by 2026, exhibiting a CAGR of 4.4% during the forecast period.

EU Migraine Market is likely to grow at remarkable rate during the forecast period. Migraines are a source of both lost productivity and medical costs The European market is the second-largest migraine drug market in the world. Growing patient population and escalating awareness among the patients relevant to the control and treatment of migraine are accelerating the market growth Germany, and France are the major contributors to the European region’s migraine drug market.

Market Dynamics

Market Growth Drivers Analysis

Prevalence of migraines is a crucial driver for this market. Today, many individuals suffer from migraine headaches. The rate of individuals getting these headaches is rising every year. The rise of these headaches is still unknown. However, the factors that trigger migraines are many. Lifestyle changes, poor food habits and underlying health conditions are factors causing migraine pain. Even though, it is not a chronic illness the severity of the headache is high. Some cases of migraine may fade away within minutes, days or weeks. However, if the condition continues proper checkups and drugs is essential to control.

Further, the patients already having migraine conditions require to take proper prevention drugs. Due to these factors, the demand for the migraine market is immense for the forecast period. The awareness about migraine is inclining the customers to take proper clinical drugs to control it. Earlier, many mistake migraines for ordinary headaches. Today, the high awareness creates more demand for the migraine market. Migraine in the female population is another crucial driver for this market. More than men women suffer from migraines during menstruation. It is another sector that will enhance the demand for the migraine market.

Market Restraints

The side effects associated with migraine drugs is a major market restraint. Migraine drugs can provide immediate relief to the user. In the case of using preventive drugs, the risks of getting a migraine are lower. There are several benefits of taking proper migraine drugs. However, like any there drugs, the side effects of migraine drugs are restraining factors. Some of these side effects can be mild. In few cases, it can affect daily activities. Drowsiness, sleepy feeling and other side effects can hamper the demand for the market. The side effects of the drugs can impede the migraine medications market growth.

COVID-19 impact on “EU Migraine Drug Market” 

The coronavirus pandemic has a damaging effect on several global markets. The health sector is busy with covid cases and patient care. The pharmaceutical and drug development industries demand rate is surging during this period. However, the market operations of the migraine market are affected due to the virus outbreak. The pharmaceutical industry is testing various drugs for the treatment of covid 19. Also, the testing of migraine drugs for covid is creating a positive impact on the market. The research of various dirges is tremendous during this period. Most of the biopharmaceutical companies are using this period to develop the drugs. The migraine drug market is taking measures of the drug compositions and their effects. The extensive research on the migraine market will increase the demand. Also, more range of drugs and treatments will be available in the upcoming years. All this will benefit the overall migraine market.

Competitive Landscape

The competition in the migraine market is immense. The low-cost drugs by local competitors are a limitation in the market. Various product awareness strategies will happen in the market during the forecast period. Market acquisition, expansions, and innovation are part of the competitive landscape. The high investment will improve the overall performance of the market.

Key Players

Key players operating in the Europe Migraine Drugs Market profiled in this report are Allergan, GlaxoSmithKline, Pfizer, Endo, Impax Laboratories. The other prominent vendors the market include AbbottAenel BioPharma, Alder Biopharmaceuticals, Amgen, Astellas, Bayer, Colucid, Eli Lilly. ptelGenx, Ethypharm, Johnson & Johnson, Kowa Pharmaceuticals America, Klaria, Luitpold Pharmaceuticals, AstraZeneca, Meda, Dr. Redoy’s Laboratories, OptiNose, Pfizer, Pozen, Eisai, Raptor, RedHill, SUDA, Teva, Aegis Therapeutics, Merck, TC Therapeutics, Nvaleant, Winston Pharmaceuticals, Allergan, and Zogenix.

Products in Pipeline

The Migraine Pipeline landscape is robust and fueled with new therapies which hold the promise to change the migraine treatment regimen in coming years.The key Migraine Pipeline drugs are Zavegepant, STS-101, Atogepant, LY-3451838, ALLOD 2, TRV-250, Prabotulinumtoxin A, HTL 0022562, UB 313, PUR-3100, TD 0148A, and others.

Notable Recent Deals

Biohaven Pharmaceutical Holding Company and Pfizer have partnered to market the Connecticut-based company’s migraine drug Nurtec ODT (rimegepant) outside of the United States once approved by global regulatory organizations.

For Biohaven, the partnership with Pfizer is valued at up to $1.24 billion in combined upfront and milestone payments. Biohaven will also receive tiered double-digit royalties under the collaboration. Nurtec ODT is currently under review by the European Medicines Agency and several additional regulatory authorities outside of the U.S.

Healthcare Policies and Regulatory Landscape

Pricing and Reimbursement scenario of Migraine Drugs

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended granting a marketing authorisation for Emgality (galcanezumab), a monoclonal antibody for the prevention of migraine.

1. Report Description of the EU Migraine Drug Market
1.1 Research Scope and Assumption
1.2 Objective of the study
1.3 Research Methodology
1.4 Reason to buy the report
2. EU Migraine Drug Market Executive Summary
2.1 EU Migraine Market – Industry Snapshot & key buying criteria, 2020-2026
2.2 Market Size, Growth Prospects and Key findings
3. Market Dynamics of EU Migraine drug market
3.1 Market Growth Drivers Analysis
3.1.1 Growing Migraine Population
3.1.2 Increased Awareness in Anti-migraine Drugs
3.2 Market Restraints Analysis
3.2.1 Side-effects Associated with Migraine Drugs
3.3 Covid-19 Market Impact Analysis
3.3.1 Positive Impact on EU Migraine Drug Market
4. EU Migraine Drugs Market Segmentation
4.1 By Treatment Type Analysis:
4.1.1 Abortive Treatment
4.1.2 Preventive Treatment
4.2 By Drug Type Analysis:
4.2.1 Detoxification Anticonvulsant
4.2.2 Antidepressant
4.2.3 Beta Blocker
4.2.4 Triptans (Serotonin Receptor Agonists)
4.2.5 Ergotamine Derivative
4.3 By Route of Administration Analysis:
4.3.1 Oral
4.3.2 Injections
4.3.3 Others
4.4 By Distribution Channel Analysis:
4.4.1 Hospital Pharmacies
4.4.2 Retail Pharmacies
4.4.3 Online Pharmacies
4.5 By End-Users Analysis:
4.5.1 Male
4.5.2 Female
5. EU Migraine Drug Major Products Market Share
5.1 Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape
6.1 Major Top Market Players
6.2 Products in Pipeline
6.3 R&D Initiatives in Migraine Drugs Market
6.4 Notable recent deals in Migraine Drugs Market
6.4.1 Joint Ventures
6.4.2 Partnerships
6.4.3 Mergers & Acquisitions
6.4.4 Strategic divestments
7. Key Company Profiles
7.1 Allergan Company overview
Product & Services, Strategies & Financials
7.2 GlaxoSmithKline Company overview
Product & Services, Strategies & Financials
7.3 Pfizer Company overview
Product & Services, Strategies & Financials
7.4 Endo Company overview
Product & Services, Strategies & Financials
7.5 Impax Laboratories Company overview
Product & Services, Strategies & Financials
7.6 AbbottAenel Company overview
Product & Services, Strategies & Financials
7.7 BioPharma Company overview
Product & Services, Strategies & Financials
7.8 Alder Biopharmaceuticals Company overview
Product & Services, Strategies & Financials
7.9 Amgen
Product & Services, Strategies & Financials
7.10 Bayer
Product & Services, Strategies & Financials
7.11 Johnson&Johnson
Product & Services, Strategies & Financials
7.12 Kowa Pharmaceuticals
Product & Services, Strategies & Financials
7.13 Dr, Redoy’s Laboratories
Product & Services, Strategies & Financials
7.14 Aegis Therapeutics
Product & Services, Strategies & Financials
7.15 TC Therapeutics
Product & Services, Strategies & Financials
7.16 Winston Pharmaceuticals
Product & Services, Strategies & Financials
7.17 Nvalean
Product & Services, Strategies & Financials
7.18 AstraZeneca
Product & Services, Strategies & Financials
7.17 OptiNose
Product & Services, Strategies & Financials
7.18 Pfizer
Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape
8.1 Pricing and Reimbursement scenario
8.2 Government Initiatives / Intervention programs
9. Factors Driving Future Growth
9.1 New Trends and Development of Migraine Drugs market
9.2 Future Opportunities
10. Strategic Recommendations

Migraine Drug Market Segmentation

Treatment Type:

In terms of treatment type, the market is segmented in to Abortive Medicine and Preventive Medicine

  • Abortive Medicine
  • Preventive Medicine

Drug type:

The drugs which are used for the treatment of the migraine include the likes of Anticonvulsant, Antidepressant, Beta Blocker, Triptans (Serotonin Receptor Agonists), Ergotamine Derivative. Moreover, the report provides information and revenues of the major branded drugs in the market for migraine

  • Anticonvulsant
  • Beta Blocker
  • Triptans (Serotonin Receptor Agonists)
  • Ergotamine Derivative

Route of Administration:

The EU migraine drugs market is segmented into oral, injectable and others. Other’s segment of route of administration includes nasal sprays, transdermal patches, etc. Low cost and vast availability of orally administrable drugs is projected to contribute for dominating share of oral segment of route of administration.

  • Oral
  • Injection
  • Others

Distribution Channel:

  • Hospital-based Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Based on the Based on Distribution Channel, the market is bifurcated into Hospital-based Pharmacies, Retail Pharmacies, Online pharmacies and Others

End-users:

The end-users segment of market has male and female. The female user’s segment registers for the highest market share in 2019 and is set to continue for the forecast period 2020-2028, owing to the increased migraine issue in the female population. According to a study conducted by different organizations, it is found that females need more meditation as they are more severe to the migraine than that of males. The male population using drugs for migraine are increasing but not as much as the female population. Increased research and development of new drugs are driving the growth of the market during the forecast period 2020-2025.

  • Male
  • Female

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.



    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements